BNP PARIBAS FINANCIAL MARKETS - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129,897
+67.0%
18,244
+139.0%
0.00%
Q2 2023$77,780
+403.9%
7,633
+348.5%
0.00%
Q1 2023$15,437
+1931.2%
1,702
+1505.7%
0.00%
Q4 2022$760
-99.9%
1060.0%0.00%
Q3 2022$691,000
+35.2%
1060.0%0.00%
Q2 2022$511,000
-15.1%
1060.0%0.00%
Q1 2022$602,000
-68.7%
106
-72.3%
0.00%
Q4 2021$1,923,000
+172.8%
383
+261.3%
0.00%
Q3 2021$705,000
-55.4%
106
-59.1%
0.00%
Q2 2021$1,582,000
-71.2%
259
-68.7%
0.00%
Q1 2021$5,500,000
+0.4%
827
-20.2%
0.00%
Q4 2020$5,480,000
-43.7%
1,036
-20.7%
0.00%
Q3 2020$9,730,000
+557.9%
1,306
+549.8%
0.00%
Q2 2020$1,479,000
+456.0%
201
+458.3%
0.00%
Q1 2020$266,000
+30.4%
360.0%0.00%
Q4 2019$204,000
-95.5%
36
-95.3%
0.00%
Q3 2019$4,547,000
+85.6%
7680.0%0.00%
Q2 2019$2,450,000
-47.3%
768
-50.5%
0.00%
Q1 2019$4,653,000
+260.7%
1,551
+352.2%
0.00%
Q4 2018$1,290,000
+2.7%
343
+60.3%
0.00%
Q3 2018$1,256,000
+3.7%
2140.0%0.00%
Q2 2018$1,211,000
-92.3%
214
-83.2%
0.00%
Q1 2018$15,760,0001,2710.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 3,247,005$10,358,0000.56%
Orbimed Advisors 3,409,865$10,877,0000.17%
Eversept Partners, LP 174,297$556,0070.16%
Alambic Investment Management, L.P. 59,847$191,0000.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,500$196,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 36,921$118,0000.00%
Paloma Partners Management Co 30,000$96,0000.00%
Tower Research Capital LLC (TRC) 3,211$10,0000.00%
SG Americas Securities, LLC 12,877$41,0000.00%
MEEDER ASSET MANAGEMENT INC 967$3,0000.00%
View complete list of SCPHARMACEUTICALS INC shareholders